Evidence map›Paper›PMID 7573371›Full record

ArticleThe American journal of pathology1995

Characterization of psoriasiform and alopecic skin lesions in HLA-B27 transgenic rats.

H Yanagisawa, J A Richardson, J D Taurog, R E Hammer

Abstract read
In one paragraph

Article in The American journal of pathology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 30 citations in OpenAlex.

  1. Models in the Research Process of Psoriasis.International journal of molecular sciences · 2017
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

H YanagisawaDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas 75235-9050, USA.
J A Richardson
J D Taurog
R E Hammer
Center for Systems Biology · US

Funding

XERODERMA PIGMENTOSUM VARIANT--GENETIC ANALYSIS AND GENE MAPPINGP30AR041940 · NIAMS · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI BERGSTRESSER, PAUL R · 1992 to 2005
$3.7M
ROLE OF HLA-B27 IN EXPERIMENTAL SPONDYLOARTHROPATHYR01AR038319 · NIAMS · UT SOUTHWESTERN MEDICAL CENTER · PI TAUROG, JOEL D · 1986 to 2009
$3.4M
NIAMS NIH HHS AR38319NIAMS NIH HHS AR41940
6 · The paper itself

Abstract

We have previously reported a multisystem inflammatory disease in transgenic rat lines with high expression of HLA-B*2705 and human beta 2 microglobulin. Skin disease in these rats includes two predominant lesions: 1) marked psoriasiform dermatitis of the tail and digits; and 2) progressive alopecia of face, neck, trunk, and extremities. Here we present the results of a systematic survey of these lesions. Tail and digit skin showed psoriasiform hyperplasia of the epidermis associated with parakeratosis, with marked dermal and epidermal inflammation. The alopecic skin showed perifollicular and follicular mononuclear infiltration and increased numbers of atrophic follicles. Immunohistochemical analysis revealed that B27 expression was prominent on keratinocytes in hyperplastic epidermis where lymphocytic infiltrates were prominent, but was absent in the absence of inflammation. In alopecic lesions, B27 was strongly expressed on follicular epithelium and dermal hair papillae associated with mononuclear infiltrates. T cells, both CD8 and CD4, were most prominent in inflammatory lesions and rat MHC-II expression on keratinocytes, and follicular epithelium was dramatically increased. This study suggests that T cell-mediated immune mechanisms participate in development of cutaneous lesions in HLA-B27 transgenic rats.

Indexed as

AlopeciaAnimalsAnimals, Genetically ModifiedFemaleHair FollicleHLA-B27 AntigenImmunohistochemistryMalePsoriasisRatsSkinTailHLA-B27 Antigen

Identifiers

PMID7573371
PMCPMC1871004
OpenAlexW198775661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.